{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:24:43Z","timestamp":1790879083661,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jacc.2020.03.047","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T16:40:50Z","timestamp":1589215250000},"page":"2463-2477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions"],"prefix":"10.1016","volume":"75","author":[{"given":"Babar","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Budts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hoodbhoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Cheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Koestenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Meinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Olga","family":"Mocumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganna D.","family":"Radchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Sallmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Krishna","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.03.047_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A\u00a0global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacc.2020.03.047_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2018.02.036","article-title":"Pulmonary hypertension registry of Kerala, India (PRO-KERALA)\u2014clinical characteristics and practice patterns","volume":"265","author":"Harikrishnan","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.047_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijcard.2016.06.242","article-title":"The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry","volume":"221","author":"Thienemann","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.047_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-2600(18)30268-6","article-title":"Pulmonary hypertension: the unaddressed global health burden","volume":"6","author":"Rich","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacc.2020.03.047_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.047_bib6","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.047_bib7","doi-asserted-by":"crossref","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jacc.2020.03.047_bib8","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jacc.2020.03.047_bib9","doi-asserted-by":"crossref","first-page":"1802148","DOI":"10.1183\/13993003.02148-2018","article-title":"An overview of the 6th World Symposium on Pulmonary Hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jacc.2020.03.047_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","article-title":"2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN)","volume":"38","author":"Hansmann","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2020.03.047_bib11","doi-asserted-by":"crossref","first-page":"ii86","DOI":"10.1136\/heartjnl-2015-309132","article-title":"Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network","volume":"102","author":"Hansmann","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.047_bib12","doi-asserted-by":"crossref","first-page":"1801904","DOI":"10.1183\/13993003.01904-2018","article-title":"Diagnosis of pulmonary hypertension","volume":"53","author":"Frost","year":"2019","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jacc.2020.03.047_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/16000617.0063-2015","article-title":"Pulmonary arterial hypertension: the burden of disease and impact on quality of life","volume":"24","author":"Delcroix","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jacc.2020.03.047_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019845604","article-title":"Analysis of pulmonary hypertension patient survival after treatment in referral center (data of first Ukrainian register)","volume":"9","author":"Radchenko","year":"2019","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2020.03.047_bib15","first-page":"375","article-title":"A\u00a0global perspective on the epidemiology of pulmonary hypertension","volume":"31","author":"Mocumbi","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.047_bib16","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/eurheartj\/eht393","article-title":"Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry","volume":"34","author":"Sliwa","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.047_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.21693\/1933-088X-15.3.144","article-title":"Pulmonary vascular diseases secondary to schistosomiasis","volume":"15","author":"Butrous","year":"2017","journal-title":"Advances in Pulmonary Hypertension"},{"key":"10.1016\/j.jacc.2020.03.047_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.047_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12890-018-0667-8","article-title":"Pulmonary arterial hypertension in Latin America: epidemiological data from local studies","volume":"18","author":"Valverde","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jacc.2020.03.047_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/heartasia-2015-010645","article-title":"Surgical strategies for patients with congenital heart disease and severe pulmonary hypertension in low\/middle-income countries","volume":"7","author":"Talwar","year":"2015","journal-title":"Heart Asia"},{"key":"10.1016\/j.jacc.2020.03.047_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2008.150086","article-title":"Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001\u20132006","volume":"95","author":"Haworth","year":"2009","journal-title":"Heart"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2020.03.047_bib22","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/heartjnl-2014-307200","volume":"102","author":"Koestenberger","year":"2016","journal-title":"Heart"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2020.03.047_bib23","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2015-307792","volume":"102","author":"Lammers","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.047_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1017\/S1047951110001988","article-title":"Decline in arterial partial pressure of oxygen after exercise: a surrogate marker of pulmonary vascular obstructive disease in patients with atrial septal defect and severe pulmonary hypertension","volume":"21","author":"Laksmivenkateshiah","year":"2011","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jacc.2020.03.047_bib25","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.112.106609","article-title":"Amelioration of high cardiac output and pulmonary hypertension by occlusion of congenital porto-systemic shunt","volume":"126","author":"McKie","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.047_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1086\/680355","article-title":"Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension","volume":"5","author":"Milger","year":"2015","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2020.03.047_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12890-017-0549-5","article-title":"Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis","volume":"17","author":"Bigna","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jacc.2020.03.047_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijcard.2009.11.006","article-title":"Challenges on the management of congenital heart disease in developing countries","volume":"148","author":"Mocumbi","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.047_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(08)60417-1","article-title":"Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study","volume":"371","author":"Sliwa","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.03.047_bib30","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ejhf.594","article-title":"Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology","volume":"18","author":"Sliwa","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2020.03.047_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1378\/chest.11-0483","article-title":"The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension","volume":"141","author":"Fernandes","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2020.03.047_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1164\/rccm.201101-0146OC","article-title":"Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis","volume":"184","author":"Crosby","year":"2011","journal-title":"Am\u00a0J Resp Crit"},{"key":"10.1016\/j.jacc.2020.03.047_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/VHRM.S92799","article-title":"Pulmonary hypertension in Nigerian adults with sickle cell anemia","volume":"13","author":"Amadi","year":"2017","journal-title":"Vasc Health and Risk Manag"},{"key":"10.1016\/j.jacc.2020.03.047_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2020.03.047_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz217","article-title":"Cardiovascular manifestations of sickle cell disease","author":"Hammoudi","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.047_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2020.03.047_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST","article-title":"An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease","volume":"189","author":"Klings","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2020.03.047_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2014-12-614370","article-title":"Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease","volume":"126","author":"Detterich","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2020.03.047_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.113.002124","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in a large group of \u03b2-thalassemia patients using right heart catheterization: a Webthal study","volume":"129","author":"Derchi","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.047_bib40","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/hrt.2005.079970","article-title":"Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia","volume":"92","author":"Phrommintikul","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.047_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/03630269.2011.605499","article-title":"Thrombosis in thalassemia: why are we so concerned?","volume":"35","author":"Musallam","year":"2011","journal-title":"Hemoglobin"},{"key":"10.1016\/j.jacc.2020.03.047_bib42","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood-2003-09-3094","article-title":"Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E\/\u03b2-thalassemia patient","volume":"103","author":"Atichartakarn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2020.03.047_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.2008.01192.x","article-title":"Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia","volume":"82","author":"Karimi","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jacc.2020.03.047_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3324\/haematol.2012.082065","article-title":"Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jacc.2020.03.047_bib45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.hlc.2016.11.003","article-title":"Comparing the efficacy of tadalafil versus placebo on pulmonary artery systolic pressure and right ventricular function in patients with beta-thalassaemia intermedia","volume":"26","author":"Jalalian","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2020.03.047_bib46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.201006-0836OC","article-title":"HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era","volume":"183","author":"Crothers","year":"2011","journal-title":"Am J Respir Crit"},{"key":"10.1016\/j.jacc.2020.03.047_bib47","first-page":"98","article-title":"Cardiac dysfunction among people living with HIV: a systematic review and meta-analysis","volume":"7","author":"Erqou","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2020.03.047_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12981-015-0078-3","article-title":"HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment","volume":"12","author":"Bigna","year":"2015","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jacc.2020.03.047_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1183\/09031936.00094808","article-title":"Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension","volume":"33","author":"Degano","year":"2009","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jacc.2020.03.047_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318360-000000000-00000","article-title":"Phosphodiesterase type 5 inhibitors for high-altitude pulmonary hypertension","volume":"30","author":"Jin","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacc.2020.03.047_bib51","first-page":"399","article-title":"Transcatheter closure of large patent ductus arteriosus at high altitude with a novel nitinol device","volume":"79","author":"Heath","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2020.03.047_bib52","series-title":"Textbook of Pulmonary Vascular Disease","first-page":"1223","article-title":"Pulmonary hypertension and congenital heart defects at high altitude","author":"Heath de Freudenthal","year":"2011"},{"key":"10.1016\/j.jacc.2020.03.047_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1047951109003941","article-title":"Advanced pulmonary vascular disease: the Eisenmenger syndrome","volume":"19","author":"Kumar","year":"2009","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jacc.2020.03.047_bib54","first-page":"e18","article-title":"Patent ductus arteriosus stenting (transcatheter Potts shunt) for palliation of suprasystemic pulmonary arterial hypertension: a case series","volume":"6","author":"Boudjemline","year":"2013","journal-title":"Circ: Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2020.03.047_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.chest.2019.03.003","article-title":"Use of balloon atrial septostomy in patients with advanced pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"156","author":"Khan","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2020.03.047_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001053","article-title":"Schistosomiasis research in the dongting lake region and its impact on local and national treatment and control in China","volume":"5","author":"McManus","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jacc.2020.03.047_bib57","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCULATIONAHA.114.006978","article-title":"Human immunodeficiency virus-associated pulmonary arterial hypertension: considerations for pulmonary vascular diseases in the developing world","volume":"131","author":"Butrous","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.047_bib58","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200404-445OC","article-title":"Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"170","author":"Sitbon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2020.03.047_bib59","first-page":"330","article-title":"Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces","volume":"4","author":"Lopes","year":"2014","journal-title":"Pulmonary Vascular Research Institute (PVRI) Pulm Circ"},{"key":"10.1016\/j.jacc.2020.03.047_bib60","first-page":"665","article-title":"Assessment of operability of congenital cardiac shunts with increased pulmonary resistance","volume":"71","author":"Viswanathan","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2020.03.047_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2015.08.155","article-title":"Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension","volume":"202","author":"Douwes","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.047_bib62","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1183\/09031936.00140112","article-title":"TOPP Registry Investigators Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice","volume":"42","author":"Beghetti","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2020.03.047_bib63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijcard.2015.10.087","article-title":"Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension)","volume":"203","author":"Beghetti","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.047_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2005.02.019","article-title":"Portopulmonary hypertension in pediatric patients","volume":"147","author":"Condino","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jacc.2020.03.047_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.2009.169904","article-title":"Comparison of 6-min walk test distance and cardiopulmonary exercise test performance in children with pulmonary hypertension","volume":"96","author":"Lammers","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jacc.2020.03.047_bib66","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2020.03.047_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.anclin.2013.10.005","article-title":"The anesthetic management of children with pulmonary hypertension in the cardiac catheterization laboratory","volume":"32","author":"Twite","year":"2014","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.jacc.2020.03.047_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/aeh172","article-title":"Anaesthetic implications of grown-up congenital heart disease","volume":"93","author":"Lovell","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2020.03.047_bib69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrcardio.2015.6","article-title":"Treatment of pulmonary arterial hypertension in children","volume":"12","author":"Latus","year":"2015","journal-title":"Nature Reviews Cardiology"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720347367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720347367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:33:51Z","timestamp":1760016831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720347367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":69,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0735109720347367"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.03.047","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.03.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}